Pulmonx Corp (LUNG) — Institutional Holders, Q2 2026 (page 2)
108 institutional investment managers reported a LUNG position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $34.1M. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 101 to 108. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
LUNG 13F holders ranked 101–108 of 108
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 101 | Wealth Enhancement Services#101 · 64 sh | 64 | $83.00 | — | New |
| 102 | Transamerica Financial Advisors#102 · 45 sh | 45 | $58.00 | 0.00% | -19.6% |
| 103 | Caitong International Asset Management , Ltd#103 · 40 sh | 40 | $52.00 | 0.00% | +471.4% |
| 104 | Clearstead Advisors#104 · 39 sh | 39 | $52.00 | 0.00% | New |
| 105 | SBI Securities , Ltd.#105 · 15 sh | 15 | $20.00 | — | 0.0% |
| 106 | FIFTH THIRD BANCORP#106 · 12 sh | 12 | $16.00 | 0.00% | 0.0% |
| 107 | Union Bankshares#107 · 10 sh | 10 | $13.00 | 0.00% | 0.0% |
| 108 | JPL Wealth Management#108 · 9 sh | 9 | $12.00 | 0.00% | New |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.